Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT and SPIKEVAX X Injection.

Conditions: SARS-CoV-2 Interventions: Biological: SPIKEVAX Bivalent; Biological: SPIKEVAX X Sponsors: ModernaTX, Inc. Recruiting

Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials